Alzchem Group Ag · XETR:ACT
Alzchem — Q1 2022 Earnings Presentation
33 slides from Alzchem's earnings presentation, Apr 28, 2022
Slide 1: Agile Science Pure Results
AGILE SCIENCE PURE RESULTS
Slide 2: Q1 2022
Q1 2022 ANDREAS NIEDERMAIER, CEO DR. GEORG WEICHSELBAUMER, CSO April 28, 2022
Slide 3: Disclaimer
DISCLAIMER CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements about the business, financial condition and earnings performance of the Alzchem Group. These statements are based on assumptions and projections resting upon currently available info
Slide 4: Agenda — Analyst Presentation Q1 2022
AGENDA — ANALYST PRESENTATION Q1 2022 Executive Summary
Slide 5: Highlights
HIGHLIGHTS Successful start to the year 2022 with sales at all-time high level Optimization project Strongest 1st quarter sales, “ oi ” 9 q afl AlzFit 2025” led to Focus on Creapure® demand remains strong several production Caen Te eeneneion with order backlogs well A cost reductions and Efe vy abov
Slide 6: Financial Overview
FINANCIAL OVERVIEW Sales growth of 25% with stable EBITDA, 18,2% price increases SALES (in M€) EBITDA (in M€) EBITDA margin (in %) Earnings per Share (in €) +24.0% 42.1% -2.8pp 2.4% Volume Price Currency
Slide 7: Turbulent Market Environment — Current Development
lzchem Group AG / April 2022 TURBULENT MARKET ENVIRONMENT — CURRENT DEVELOPMENT Logisic-, raw material und energy costs Power front year 340,00 290,00 ¥ 240,00 = 190,00 2 @B 140,00 90,00 40,00 Natural gas EUR/MWh © Ss ° 8 Crude oil (Brent) USD/Barrel Met-Coke
Slide 8: Agenda — Analyst Presentation Q1 2022
AGENDA — ANALYST PRESENTATION Q1 2022 ll. Business and financial details
Slide 9: Basics & Intermediates
NITRALZ® perl ka’ G al BASICS & INTERMEDIATES The "Basics & Intermediates" segment comprises the production of basic and intermediate products that are marketed as independent products for example in agriculture, steel production and the automotive sector and as raw materials for the manufacture of
Slide 10: Basics & Intermediates Segment (in M€)
BASICS & INTERMEDIATES SEGMENT (in Mé€) Sales significantly above prior year SALES ANALYSIS Qi Q2. Q3) O4 QI Q2 Q3 QA 2020 2020 2020 2020 2021 2021 2021 2021 2022 [2 71 Qi Q2. Q3) 4 Qt 2 3 4A 1-3 1-3 1-3 1-3 2020 2020 2020 2020 2021 2021 2021 2021 2022 2021 2022 2021 2022
Slide 11: Specialty Chemicals
s CREAMINO [Drmex’ Bioselect? DYHARD #88 Creapure® SPECIALTY CHEMICALS The "Specialty Chemicals" segment produces and sells high-quality growth products in the area of specialty chemicals.
Slide 12: Specialty Chemicals Segment (in M€)
SPECIALTY CHEMICALS SEGMENT (in m€) Encouraging business performance 4 a> LES ANALYSIS 65.3 56.8 Qi Q2. Q3- QA QI Q2 Q3 4 QI 2020 2020 2020 2020 2021 2021 2021 2021 2022 COMMENTS Demand for custom manufacturing DYHARD® (automotive sector) as w sector) on a persistent high Successful strategic market
Slide 13: Other & Holding
OTHER & HOLDING The "Other & Holding" segment offers infrastructure and energy supply services at our locations for the chemicals segments and for external customers. alzchem me group
Slide 14: Other & Holding Segment (in M€)
OTHER & HOLDING SEGMENT (in me) Development of services in line with 2021 SALES ANALYSIS Qi Q2. Q3- QA QI Q2 Q3 4 QI 2020 2020 2020 2020 2021 2021 2021 2021 2022 COMMENTS Stabl 2 in line with affected the Tim ed p C ° to support EBITDA -0.1 -01 Qi Q2. Q3) O4 QI Q2 Q3 QA 1-3 1-3 2020 2020 2020 2020 2
Slide 15: Balance Sheet (in M€)
BALANCE SHEET (in mé) Increase of balance sheet total and equity ratio 197.2 Other non-current assets 19.4 Deferred taxes for pension provision 26.0 107.6 Inventories 867 Trade receivables _meyee (Other current assets 31.12.2021 31.03.2022 mainly r le ts for ra also impa c e availability Equity Othe
Slide 16: Cashflow (in M€)
CASHFLOW (in me) Strong net cashflow impacted by business growth on both directions & n sin
Slide 17: Implementing Operating Targets
© Alzchem Group AG / April 2022 IMPLEMENTING OPERATING TARGETS I Focus on the key growth drivers and sustainability Implementation of price increases, at least in the amount of the cost increases SUSTAINABILITY * — Set the path to CO, neutral growth and climate neutrality by 2045 * Vision 0 accident
Slide 18: Outlook 2022 (in M€)
OUTLOOK 2022 (in M€) Parity of cost with price increases will determine EBITDA COMMENTS * Adjustment of the upper sales limit from 480 M€ to 520 M€ due to necessary price increases strongly to ill determ EBITDA — balance pany short term needs with long-term requirements increasing . Further gi h of
Slide 19: Financial Calendar
FINANCIAL CALENDAR Upcoming dates MAY 5 MAY 23 - 24 JUL 26 SEP 5 = © SEP 21 SEP 22 OCT 26 NOV 15 - 16 NOV 28 - 30 2022 2022 2022 2022 2022 2022 2022 2022 2022 Annual General Meeting 2022 German Spring Conference Half-Year Financial Report 2022 Fall Conference Berenberg and Goldman Sachs German Corpo
Slide 20: Investor Relations
alzchem group Investor Relations T +49 8621 86-2888 F +49 8621 86-502888 ir@alzchem.com
Slide 21: Agenda — Analyst Presentation Q1 2022
AGENDA — ANALYST PRESENTATION Q1 2022
Slide 22: Balance Sheet
BALANCE SHEET Alzchem Group © Alzchem Group AG / Feb 2022 ALZCHEM GROUP (IN TE) 3112.2021 31.03.2022 Deviation ALZCHEM GROUP (IN TE} 31122021 31.03.2022 Deviation Intangible assets 2,329 2,257 2 -3.1% Share capital 101,763 101,763 Tangible assets 178,806 178,136 -670 -0.4% RETAINED EARNINGS (+) / LO
Slide 23: Pension Accounting (IFRS)
PENSION ACCOUNTING (IFRS) Alzchem Group (M€) IN FINANCIAL PENSION SERVICE NET INTEREST PENSION STATEMENT PROVISION costs PAYMENTS 31.12.2021 FINAN RESULT BALANCE SHEET P&L CASHFLOW, Adjustment of market interest rate from 0.5 % > 1.0 %; decreasing impact on provision Adjustment of expected pension t
Slide 24: Income Statement
INCOME STATEMENT Alzchem Group ALZCHEM GROUP (IN TE) 2 a o a oO oo oo oe Deviation (Q1) Revenue 104,321 111,000 95,920 111,052 129,395 25,073 24% Increase (+) / Decrease (-)ininventories offinished goo. 2,144 1,621 «6350 7,442 14144 16,288. -760% Other income 3,983 2505 2,432,729 4070 a % Raw materi
Slide 25: Income Statement
INCOME STATEMENT Alzchem Group ALZCHEM GROUP (IN TE) Sh Aon Deviation (200) Revenue 104321 129,395 25073 240% Increase (+) / Decrease (-) in inventories of finished goods and work in progress “2144 144g 16288 -759.8% Other income 3,983 4070 ar 22% Raw materials and consumables used -36226 -73,537 -3
Slide 26: Cashflow Statement
© Alzchem Group AG / April 2022 CASHFLOW STATEMENT Alzchem Group Qi Qi CASHFLOW (IN M€) 2021 apa Consolidated earnings before taxes 11,039 11343 Depreciation on fixed and intangible assets 5771 6,305 Decrease in pension provisions 420 513 Loss (+) / Profit (-) from the sale of non-current assets 2 1
Slide 27: Segment Overview by Quarter
SEGMENT OVERVIEW BY QUARTER A Alzchem Group v SALES 2020 2021 2022 YTD Qt 2022 sALes Qa 2 @ 4 Qa Q2 Q@ a QA QV_——-Q_—Q}__ deviation PYQHY PY Actual jw ot 2 20e Te je ot 8 6 jt te te Te Te % Te Te Basics & Intermediates 36,012 38,266 32,320 39,837 41,070 45,178 42,465 47,561 57,441 16,372 29% 41,070
Slide 28: Executive Team
EXECUTIVE TEAM Alzchem Group AG ~ ee fy ANDREAS NIEDERMAIER CEO WITH ALZCHEM SINCE 1999, AREAS OF RESPONSIBILITY Company Strategy, Finance & Controlling, Investor Relations & Communication, IT, Risk Management, HR, Supply Chain Management, Legal/Patents & Trademarks | | | ae ~, KLAUS ENGLMAIER coo W
Slide 29: Alzchem Group Locations
ALZCHEM GROUP LOCATIONS Production sites and sales companies @ SALES COMPANY SHANGHAI (CN) 4 ATLANTA (USA)
Slide 30: Verbund — Fully Integrated Business Model
© Alzchem Group AG / April 2022 “VERBUND” — FULLY INTEGRATED BUSINESS MODEL AN Benefits of the “Verbund” system approach (cr Segment Specialty Chemicals Segment O Basics & Inter- : * Full control of product quality and specifications mediates \ ’ BENEFITS OF “VERBUND” * Lower costs * Higher financia
Slide 31: Our Products and Markets
© Alzchem Group AG / April 2022 OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries MAIN PRODUCTS DESCRIPTION ey END-MARKETS CREAMINO’ A feed additive for broilers and pigs Feed additive 88 Creapure’ Premium brand for creatine monohydrate as a food supplement in sp
Slide 32: Our Products and Markets
© Alzchem Group AG / April 2022 OUR PRODUCTS AND MARKETS Successful with proven and new products in various industries n w = a < n ae a ta co Wi [= e OTHER & HOLDING \N MAIN PRODUCTS DESCRIPTION END-MARKETS an Calcium carbide-based mixtures for hot metal desulphurization Steel industry al Guanidine
Slide 33: Key Share Data
© Alzchem Group AG / April 2022 KEY SHARE DATA Share Details as of March 18, 2022 10,176,335 SHARES OUTSTANDING eeu aa held LAST CLOSING PRICE EUR 24.00 MARKET CAPITALIZATION EUR 244m TICKER ACT WKN A2YNT3 ISIN DEOOOA2YNT30 = ret Sn ge DESIGNATED SPONSOR Ouico Sevaloy Bank AG ey SHAREHOLDER STRUCTUR